Sort
15,842 grants matching “pancreatic cancer”
Drug Development Core
$890,415Daniel D Von Hoff · Translational Genomics Research Inst · P01 · FY2009 · CA
Cancer Immunotherapy Clinical Trials
$890,340Julius Strauss · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
The role of intracellular pH in the specification of cell fate
$890,000Todd Nystul · University Of California-San Francisco · · FY2020 · BIO
MOUSE CANCER MODELS VIA TGF-BETA RII LOSS
$888,503Vanderbilt University · U01 · FY2003 · CA
Development of TIMP-2 derivatives or strategies as biologic therapies for cancer
$888,432William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Foregut Microbiome and Risk of Gastric Intestinal Metaplasia, and Gastric Cancer Risk
$888,388Yu Chen · New York University School Of Medicine · R01 · FY2017 · CA
IGF::OT::IGF - IND ENABLING DEVELOPMENT OF NANOGMP: TARGETED
$888,375Jun Li · Qualiber, Inc. · N44 · FY2014 · CA
FUNCTIONAL GENOMICS OF THE DEVELOPING ENDOCRINE PANCREAS
$888,089Washington University · R24 · FY2001 · DK
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies
$887,976William Douglas Figg · Division Of Clinical Sciences - Nci · ZIC · FY2020 · CA
Identification of human tumor-associated antigens
$887,872Kwong Yok Tsang · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Human natural killer cells: Advancing biology and clinical applications
$886,438Michael A Caligiuri · Beckman Research Institute/City Of Hope · R35 · FY2025 · CA
Post-transcriptional control of Proliferation, Stress Response & Carcinogenesis
$886,074Myriam Gorospe · National Institute On Aging · ZIA · FY2015 · AG
RAIT of Pancreatic Cancer with Humanized PAM4
$886,058Ctr For Molecular Medicine/Immunology · R01 · FY2005 · CA
Reprogramming PDAC Stroma by Targeting Coagulation in the Tumor Microenvironment
$885,794Bumsoo Han · University Of Illinois At Urbana-Champaign · U01 · FY2024 · CA
Development of a companion diagnostic to identify patients who respond to microbiome-targeting drugs
$884,165Bret David Wallace · Symberix, Inc. · R44 · FY2020 · GM
DIETARY INFLUENCE ON LIVER METASTASIS IN PANCREATIC CANCER
$883,531Sloan-Kettering Institute For Cancer Research · · FY2022 · Department of the Army
Circulating Biomarkers and Imaging for Early Detection of Pancreatic Cancer
$883,200Subrata Sen · University Of Tx Md Anderson Can Ctr · U01 · FY2019 · CA
Using ex vivo, in vivo models and patient mutations to interrogate pancreatic exocrine-endocrine cross talk
$882,433Rohit N. Kulkarni · Joslin Diabetes Center · U01 · FY2025 · DK
SPORE in Pancreatic Cancer
$881,136Donald J. Buchsbaum · University Of Alabama At Birmingham · P20 · FY2006 · CA
CSHL-JAX Patient-Derived Models of Pancreatic Cancer as Systems for Investigating Tumor Heterogeneity
$881,016David Tuveson · Cold Spring Harbor Laboratory · U01 · FY2018 · CA
Targeting PKR-Bcl2 Signaling to Overcome Paclitaxel Resistance in Ovarian Cancer
$880,570Jixin Dong · University Of Nebraska Medical Center · R01 · FY2025 · CA
INTERFERON E AS A TUMOR SUPPRESSOR AND POTENTIAL THERAPEUTIC IN PANCREATIC CANCER
$880,000Sloan-Kettering Institute For Cancer Research · · FY2024 · Defense Health Agency
Next-Generation Antibody Discovery and Development Technology
$879,836David Scott Johnson · Gigagen, Inc. · R44 · FY2016 · CA
The Antigen Targeting Core
$879,641Maria Parkhurst · Division Of Basic Sciences - Nci · ZIC · FY2023 · CA
CANCER AND INFLAMMATION: FUNCTION AND THERAPY
$879,352Michael Dean · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA